Summary
Despite medical advances lung cancer remains the leading cause of cancer deaths. Lung cancer is usually recognized late in its natural history and at presentation in 80 % unresectable. Smoking history is the most important risk factor. At present time, sceening for lung cancer is not recommended.
The only chance for cure is tumour resection in early stages, performed in about 20 % of all lung cancer cases. Histological subtypes are non-small cell lung cancer (NSCLC) (80 % of lung cancers) and 20 % small cell lung cancer (SCLC). TNM-staging has important influence on prognosis and therapy. After identification the tumour should be staged using the TNM system. Currently diagnosis and staging rely predominantly on chest radiography and computed tomography (CT) scanning. Positron emission tomography (PET) identifies the tumour by its metabolic activity and helps to find malignant nodal or systemic leasons. Flexible bronchoscopy is the key investigation in the diagnosis and staging of patients with suspected lung cancer. Endobronchial ultrasound guided transbronchial fine needle aspiration (TBNA) may be utilized to improve the bronchoscopic results in mediastinal staging. Internistic thoracoscopy or video assisted thoracoscopic surgery (VATS) may be used in malignant pleural effusions. Mediastinoscopy staging is the gold-standard for mediastinal staging.
Schlüsselwörter
nichtkleinzelliges Lungenkarzinom - kleinzelliges Lungenkarzinom - TNM-System - Computertomographie - low-dose-Screening-CT - Morphologiesicherung - Bronchoskopie - Mediastinoskopie - Thorakoskopie - Positronen-Emissions-Tomographie
Key words
non-small cell lung cancer - small cell lung cancer - TNM-system - computed tomography - low-dose-screening-CT - bronchoscopy - mediastinoscopy - thoracoscopy - positron-emission-tomography
Literatur
-
1
Birim O. et al .
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non small cell lung cancer.
Ann Thorac Surg.
2005;
79
375-381
-
2
Bittner R C, Pech M.
Staging des Lungenkarzinoms.
Pneumologe.
2005;
2
102-110
-
3
Buccheri G, Ferrigno D.
Lung cancer: clinical presentation and specialist referral time.
Eur Respir J.
2004;
24
898-904
-
4
Dietrich C F, Braden B, Wagner T OF.
Thorax- und Lungensonographie.
Dt Ärztebl.
2000;
97
A103-110
-
5
ESMO.
Minimum clinical recommendations for diagnosis, treatment and follow-up of non-small cell lung cancer (NSCLC).
Ann Oncol.
2005 ;
(S 1)
16
i28-i29
-
6
Henschke C I. et al .
Early lung cancer action project: overall design and findings from baseline screening.
Lancet.
1999;
354
99-105
-
7 Herth F, Becker H D. Endoskopische Diagnostik: Bronchoskopie. In Drings P et al. (Hrsg.) Management des Lungenkarzinoms. Springer, Berlin 2003: 55-60
-
8 International Union against cancer .TNM classification of malignant tumours,. 5 th ed New York, NY, International Union Against Cancer 1997
-
9
Lardinois D, Weder W, Hany T F. et al .
Staging of non-small cell lung cancer with integrated positron emission tomography and computed tomography.
N Engl J Med.
2003;
348
2500-2507
-
10 Kirby T J, Stanley C F. Mediastinoscopy. In: Pearson FG, Cooper JD, Deslauries J (eds) Thoracic Surgery, Churchill Livingstone, Philadelphia 2002
-
11
Loddenkemper R.
Thoracoscopy.
Eur Respir J.
1998;
11
213-221
-
12
Markus A, Häußinger K, Hauck W, Kohlhäufl M.
Bronchoskopie in Deutschland: Querschnitterhebung an 681 Institutionen.
Pneumologie.
2000;
54
499-507
-
13
Mountain C F.
Revisions in the international system for staging lung cancer.
Chest.
1997;
111
1710-1717
-
14
Nowak D, Ochmann U, Huber R M, Diederich S.
Screening des Lungenkarzinoms - aktueller Stand.
Pneumologie.
2005;
59
178-191
-
15
Sobue T, Moriyama N, Kaneko M. et al .
Screening for lung cancer with low-dose helical computed tomography.
J Clin Oncol.
2002;
20
911
-
16
Schreiber G, McCrory D C.
Performance characteristics of different modalities for diagnosis of suspected lung cancer. Summary of published evidence.
Chest.
2003;
123
115S-128S
-
17
Thomas M, Gatzemeier U, Goerg R. et al .
Empfehlungen zur Diagnostik des Lungenkarzinoms.
Pneumologie.
2000;
54
361-371
-
18
Toloza E M, Harpole L, McCrory D C.
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
Chest.
2003;
123
137-146
-
19 Travis W D, Brambilla E, Müller-Hermelink H K, Harris C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours.Lyon, France: IARC Press 2004
-
20
Vansteenkiste J. et al .
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer.
Lancet Oncol.
2004;
5
531-540
Dr. med. Monika Serke
Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring
Walterhöferstraße 11
14165 Berlin
Phone: 030/81022329
Fax: 030/81022188
Email: mserke@berlin-behring.helios-kliniken.de
